Literature DB >> 10770278

The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation.

E Brandt1, F Petersen, A Ludwig, J E Ehlert, L Bock, H D Flad.   

Abstract

The recruitment of neutrophil granulocytes to sites of tissue injury is one of the earliest events during host defense. Several chemotactic cytokines belonging to the CXC subfamily of chemokines are thought to be implicated in this kind of response. Especially those CXC chemokines that are stored in blood platelets and become immediately released upon activation are likely to dominate neutrophil-dependent host defense at the onset of inflammation. The major platelet-derived CXC chemokines are the beta-thromboglobulins and platelet factor 4 (PF-4), which are both released into the blood at micromolar concentrations. The availability as well as the functional activity of these mediators appear to be subject to tight control by diverse regulatory mechanisms. These include proteolytic processing of chemokine precursors, oligomer formation, and the differential usage of neutrophil-expressed receptors. Herein we review our work on early neutrophil regulation by PF-4, the beta-thromboglobulin neutrophil-activating peptide 2 (NAP-2) and its major precursor connective tissue-activating peptide III (CTAP-III). We moreover propose a model to assess the contribution by either of these chemokines to coordinated recruitment and activation of neutrophils in response to acute tissue injury.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10770278     DOI: 10.1002/jlb.67.4.471

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  54 in total

Review 1.  Platelets as initiators and mediators of inflammation at the vessel wall.

Authors:  Guanfang Shi; Craig N Morrell
Journal:  Thromb Res       Date:  2010-11-20       Impact factor: 3.944

Review 2.  The Role of Chemokines in Fibrotic Wound Healing.

Authors:  Jie Ding; Edward E Tredget
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

3.  Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer.

Authors:  Charlotte H Clarke; Christine Yip; Donna Badgwell; Eric T Fung; Kevin R Coombes; Zhen Zhang; Karen H Lu; Robert C Bast
Journal:  Gynecol Oncol       Date:  2011-06-25       Impact factor: 5.482

4.  Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation.

Authors:  Alexander Zarbock; Kai Singbartl; Klaus Ley
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

Review 5.  Platelets and Their Interactions with Other Immune Cells.

Authors:  Fong W Lam; K Vinod Vijayan; Rolando E Rumbaut
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

6.  Elevated levels of CXC chemokine connective tissue activating peptide (CTAP)-III in lung cancer patients.

Authors:  Gina Lee; Brian K Gardner; David A Elashoff; Colleen M Purcell; Harpavan S Sandha; Jenny T Mao; Kostyantyn Krysan; Jay M Lee; Steven M Dubinett
Journal:  Am J Transl Res       Date:  2011-04-02       Impact factor: 4.060

7.  Leukocyte integrin Mac-1 (CD11b/CD18, αMβ2, CR3) acts as a functional receptor for platelet factor 4.

Authors:  Valeryi K Lishko; Valentin P Yakubenko; Tatiana P Ugarova; Nataly P Podolnikova
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

8.  Biologically active neutrophil chemokine pattern in tonsillitis.

Authors:  C Rudack; S Jörg; F Sachse
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 9.  Platelet alpha-granules: basic biology and clinical correlates.

Authors:  Price Blair; Robert Flaumenhaft
Journal:  Blood Rev       Date:  2009-05-17       Impact factor: 8.250

10.  PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia.

Authors:  Sofie Struyf; Evemie Schutyser; Mieke Gouwy; Klara Gijsbers; Paul Proost; Yves Benoit; Ghislain Opdenakker; Jo Van Damme; Geneviève Laureys
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.